These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 27591257)

  • 21. Decreased expression of neuropilin-1 as a novel key factor contributing to peripheral microvasculopathy and defective angiogenesis in systemic sclerosis.
    Romano E; Chora I; Manetti M; Mazzotta C; Rosa I; Bellando-Randone S; Blagojevic J; Soares R; Avouac J; Allanore Y; Ibba-Manneschi L; Matucci-Cerinic M; Guiducci S
    Ann Rheum Dis; 2016 Aug; 75(8):1541-9. PubMed ID: 26359450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF-A and neuropilin 1 (NRP1) shape axon projections in the developing CNS via dual roles in neurons and blood vessels.
    Erskine L; François U; Denti L; Joyce A; Tillo M; Bruce F; Vargesson N; Ruhrberg C
    Development; 2017 Jul; 144(13):2504-2516. PubMed ID: 28676569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Actin-Binding Protein Cortactin Promotes Pathogenesis of Experimental Autoimmune Encephalomyelitis by Supporting Leukocyte Infiltration into the Central Nervous System.
    Samus M; Li YT; Sorokin L; Rottner K; Vestweber D
    J Neurosci; 2020 Feb; 40(7):1389-1404. PubMed ID: 31911458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tuftsin-driven experimental autoimmune encephalomyelitis recovery requires neuropilin-1.
    Nissen JC; Tsirka SE
    Glia; 2016 Jun; 64(6):923-36. PubMed ID: 26880314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imatinib inhibits VEGF-independent angiogenesis by targeting neuropilin 1-dependent ABL1 activation in endothelial cells.
    Raimondi C; Fantin A; Lampropoulou A; Denti L; Chikh A; Ruhrberg C
    J Exp Med; 2014 Jun; 211(6):1167-83. PubMed ID: 24863063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
    Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P
    Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial ETS1 inhibition exacerbate blood-brain barrier dysfunction in multiple sclerosis through inducing endothelial-to-mesenchymal transition.
    Luo Y; Yang H; Wan Y; Yang S; Wu J; Chen S; Li Y; Jin H; He Q; Zhu DY; Zhou Y; Hu B
    Cell Death Dis; 2022 May; 13(5):462. PubMed ID: 35568723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signal Integration of IFN-I and IFN-II With TLR4 Involves Sequential Recruitment of STAT1-Complexes and NFκB to Enhance Pro-inflammatory Transcription.
    Piaszyk-Borychowska A; Széles L; Csermely A; Chiang HC; Wesoły J; Lee CK; Nagy L; Bluyssen HAR
    Front Immunol; 2019; 10():1253. PubMed ID: 31231385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival.
    Morin E; Sjöberg E; Tjomsland V; Testini C; Lindskog C; Franklin O; Sund M; Öhlund D; Kiflemariam S; Sjöblom T; Claesson-Welsh L
    J Pathol; 2018 Nov; 246(3):311-322. PubMed ID: 30027561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune cell trafficking across the barriers of the central nervous system in multiple sclerosis and stroke.
    Lopes Pinheiro MA; Kooij G; Mizee MR; Kamermans A; Enzmann G; Lyck R; Schwaninger M; Engelhardt B; de Vries HE
    Biochim Biophys Acta; 2016 Mar; 1862(3):461-71. PubMed ID: 26527183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms underlying the pro-inflammatory synergistic effect of tumor necrosis factor alpha and interferon gamma in human microvascular endothelium.
    Lombardi A; Cantini G; Mello T; Francalanci M; Gelmini S; Cosmi L; Santarlasci V; Degl'Innocenti S; Luciani P; Deledda C; Annunziato F; Forti G; Galli A; Serio M; Luconi M
    Eur J Cell Biol; 2009 Dec; 88(12):731-42. PubMed ID: 19782427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physical Exercise Attenuates Experimental Autoimmune Encephalomyelitis by Inhibiting Peripheral Immune Response and Blood-Brain Barrier Disruption.
    Souza PS; Gonçalves ED; Pedroso GS; Farias HR; Junqueira SC; Marcon R; Tuon T; Cola M; Silveira PCL; Santos AR; Calixto JB; Souza CT; de Pinho RA; Dutra RC
    Mol Neurobiol; 2017 Aug; 54(6):4723-4737. PubMed ID: 27447807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine-stimulated GTP cyclohydrolase I expression in endothelial cells requires coordinated activation of nuclear factor-kappaB and Stat1/Stat3.
    Huang A; Zhang YY; Chen K; Hatakeyama K; Keaney JF
    Circ Res; 2005 Feb; 96(2):164-71. PubMed ID: 15604419
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood-brain barrier genetic disruption leads to protective barrier formation at the Glia Limitans.
    Mora P; Hollier PL; Guimbal S; Abelanet A; Diop A; Cornuault L; Couffinhal T; Horng S; Gadeau AP; Renault MA; Chapouly C
    PLoS Biol; 2020 Nov; 18(11):e3000946. PubMed ID: 33253145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcryptomic Analysis of Human Brain-Microvascular Endothelial Response to -Pericytes: Cell Orientation Defines Barrier Function.
    Kurmann L; Okoniewski M; Ogunshola OO; Leeners B; Imthurn B; Dubey RK
    Cells; 2021 Apr; 10(4):. PubMed ID: 33924251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Central Nervous System Barriers Impact Distribution and Expression of iNOS and Arginase-1 in Infiltrating Macrophages During Neuroinflammation.
    Ivan DC; Walthert S; Locatelli G
    Front Immunol; 2021; 12():666961. PubMed ID: 33936108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new mechanism involving ERK contributes to rosiglitazone inhibition of tumor necrosis factor-alpha and interferon-gamma inflammatory effects in human endothelial cells.
    Lombardi A; Cantini G; Piscitelli E; Gelmini S; Francalanci M; Mello T; Ceni E; Varano G; Forti G; Rotondi M; Galli A; Serio M; Luconi M
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):718-24. PubMed ID: 18239149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-γ Drives T
    Overacre-Delgoffe AE; Chikina M; Dadey RE; Yano H; Brunazzi EA; Shayan G; Horne W; Moskovitz JM; Kolls JK; Sander C; Shuai Y; Normolle DP; Kirkwood JM; Ferris RL; Delgoffe GM; Bruno TC; Workman CJ; Vignali DAA
    Cell; 2017 Jun; 169(6):1130-1141.e11. PubMed ID: 28552348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lithium controls central nervous system autoimmunity through modulation of IFN-γ signaling.
    Rowse AL; Naves R; Cashman KS; McGuire DJ; Mbana T; Raman C; De Sarno P
    PLoS One; 2012; 7(12):e52658. PubMed ID: 23285134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of regional astrocyte interferon-γ signaling during chronic autoimmunity: a novel role for the immunoproteasome.
    Smith BC; Sinyuk M; Jenkins JE; Psenicka MW; Williams JL
    J Neuroinflammation; 2020 Jun; 17(1):184. PubMed ID: 32532298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.